GGrantIndex
← Search

Development Funds

$949,396P30FY2012CANIH

University Of Tx Md Anderson Can Ctr, Houston TX

Investigators

Linked publications, trials & patents

Trial NCT07407920Trial NCT07349641Trial NCT06651580Trial NCT05681026Trial NCT05223036Trial NCT05078866Trial NCT05057312Trial NCT05054296Trial NCT05044546Trial NCT05023967Trial NCT05011045Trial NCT04875728Trial NCT04870645Trial NCT04810091Trial NCT04751422Trial NCT04740164Trial NCT04668300Trial NCT04615013Trial NCT04505267Trial NCT04484909Trial NCT04483349Trial NCT04481204Trial NCT04474301Trial NCT04458610Trial NCT04447222Trial NCT04435691Trial NCT04430725Trial NCT04407247Trial NCT04373720Trial NCT04317781Trial NCT04311723Trial NCT04310826Trial NCT04310397Trial NCT04265430Trial NCT04257045Trial NCT04256941Trial NCT04239989Trial NCT04239976Trial NCT04239157Trial NCT04236882Trial NCT04228042Trial NCT04220827Trial NCT04220775Trial NCT04220008Trial NCT04219969Trial NCT04219904Trial NCT04216732Trial NCT04216563Trial NCT04216524Trial NCT04216472Trial NCT04215029Trial NCT04200534Trial NCT04199026Trial NCT04196972Trial NCT04189783Trial NCT04189770Trial NCT04189757Trial NCT04188418Trial NCT04188405Trial NCT04186884Trial NCT04186832Trial NCT04185337Trial NCT04181463Trial NCT04171622Trial NCT04171219Trial NCT04171037Trial NCT04169763Trial NCT04169737Trial NCT04169542Trial NCT04160052Trial NCT04151082Trial NCT04150939Trial NCT04140487Trial NCT04135326Trial NCT04134208Trial NCT04132843Trial NCT04132505Trial NCT04132440Trial NCT04129138Trial NCT04128748Trial NCT04128501Trial NCT04127721Trial NCT04125914Trial NCT04119037Trial NCT04106843Trial NCT04106245Trial NCT04090619Trial NCT04090567Trial NCT04087057Trial NCT04083378Trial NCT04082572Trial NCT04074746Trial NCT04066894Trial NCT04062305Trial NCT04062266Trial NCT04058964Trial NCT04054245Trial NCT04054167Trial NCT04054154Trial NCT04053517

Abstract

Developmental Funds continue to represent an important and critical institutional resource to support newly recruited faculty without prior peer-reviewed support into the 19 Basic Science, Clinical and Populationbased Research Programs of MDACC, to develop new shared resources in response to the research needs of peer-reviewed investigators, and to support multidisciplinary research programs. A significant increase in Developmental Funds is requested in this competitive renewal based on the institution's careful stewardship and successful return on the funds invested in newly recruited faculty during the current grant period, the plans for the Monoclonal Antibody Facility, Molecular Cytogenetics Facility, Immune Monitoring Core Laboratory, and the pilot projects of the Multidisciplinary Research Programs. Processes are in place within the institution to solicit proposals for support from CCSG Developmental Funds and to review them for scientific merit and programmatic relevance. The Developmental Funds requested will be leveraged with institutional resources to insure the scientific growth and excellence of MDACC's research programs, including the continued recruitment of outstanding new junior faculty, the ability to provide the necessary shared resource infrastructure to support research initiatives, and the flexibility to capitalize on new and innovative research leads. The Developmental Funds will provide the Director of the Cancer Center with a stable source of support for a variety of activities critical to maintaining the research strength and interactive environment characteristic of the MDACC.

View original record on NIH RePORTER →